American Society of Clinical Oncology

SHERPA: White

People

  1. O'Reilly
    O'Reilly
  2. Abou-Alfa
    Abou-Alfa
  3. Berger
    Berger
  4. Saltz
    Saltz
  5. Drilon
    Drilon
  6. Harding
    Harding
  7. Kemeny
    Kemeny
  8. Offit
    Offit
  9. Schram
    Schram
  10. Schultz
    Schultz

Groups

  1. Center for Pancreatic Cancer Research (9)
  2. Department of Medicine (9)
  3. Early Drug Development Service (9)
  4. Gastrointestinal Oncology Service (9)
  5. Solid Tumor Oncology Division (9)
  6. GSK Faculty (6)
  7. Human Oncology and Pathogenesis Program (6)
  8. Epidemiology and Biostatistics (4)
  9. Gynecologic Medicine Service (4)
  10. Population Sciences Research Program (4)
Search Within
  1. "Early Drug Development Service"
  2. "Eileen O'Reilly"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (2)
Groups
  1. Center for Pancreatic Cancer Research (9)
  2. Department of Medicine (9)
  3. Early Drug Development Service (9)
  4. Gastrointestinal Oncology Service (9)
  5. Solid Tumor Oncology Division (9)
  6. GSK Faculty (6)

More Groups

People
  1. Eileen O'Reilly (9)
  2. Michael Berger (6)
  3. David Hyman (5)
  4. David Klimstra (4)
  5. Ghassan Abou-Alfa (4)
  6. Leonard Saltz (4)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (1)
  5. 2019 (1)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
    Journal Article

    Mandelker, D.; Marra, A.; Zheng-Lin, B.; Selenica, P.; Blanco-Heredia, J.; Zhu, Y.; Gazzo, A.; Wong, D.; Yelskaya, Z.; Rai, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers
    Meeting Abstract

    Schram, A. M.; Goto, K.; Kim, D. W.; Martin-Romano, P.; Ou, S. H. I.; O'Kane, G. M.; O'Reilly, E. M.; Umemoto, K.; Duruisseaux, M.; Neuzillet, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab in advanced pancreas cancer and other solid tumors harboring NRG1 fusions
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; O'Kane, G. M.; Goto, K.; Kim, D. W.; Neuzillet, C.; Martin-Romano, P.; Duruisseaux, M.; Nagasaka, M.; Rodon, J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A. M.; Drilon, A. E.; Macarulla, T.; O'Reilly, E. M.; Rodon, J.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C.; Lam, J. Y. C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A prospective analysis of germline alterations (GA) in biliary tract cancer (BTC)
    Meeting Abstract

    Lowery, M. A.; Jordan, E.; Kemel, Y.; Mukherjee, S.; Cercek, A.; Kemeny, N. E.; Varghese, A. M.; Rusek, M.; Boucher, T. M.; Mandelker, D.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save